CynergisTek (CTEK) Stock Price, News & Analysis

Company Overview

CynergisTek, Inc. is a U.S.-based cybersecurity and privacy risk management firm specializing in the healthcare and life sciences sectors. The company provides strategic advisory services and technical solutions designed to help healthcare organizations identify, assess and remediate information security and privacy risks. By focusing exclusively on regulated industries, CynergisTek aims to address the unique compliance and regulatory challenges faced by its clients.

The firm’s core offerings include security risk assessments, HIPAA privacy and security compliance reviews, penetration testing, vulnerability management, incident response planning and workforce training. CynergisTek also delivers managed security services, such as continuous monitoring and third-party risk management, to support clients’ ongoing security programs. Its team of consultants combines clinical, technical and regulatory expertise to tailor solutions that align with each organization’s size and maturity level.

Headquartered in Austin, Texas, CynergisTek serves healthcare providers, health plans, life sciences companies, and technology vendors throughout North America. The company’s practitioners work with hospitals, physician groups, payers and software developers to implement robust cybersecurity frameworks, maintain regulatory compliance and safeguard patient data. CynergisTek’s experience in regulated environments positions it as a trusted partner for organizations seeking to strengthen their security posture.

Key Stats

• Today's Range: $1.23 to $1.25
• 50-Day Range: $1.25 to $1.25
• 52-Week Range: $0.58 to $2.04
• Volume: 167,600 shs
• Average Volume: 293,474 shs
• Market Capitalization: $16.57 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CTEK Stock Analysis - Frequently Asked Questions

How have CTEK shares performed this year?

CynergisTek's stock was trading at $1.25 at the beginning of the year. Since then, CTEK shares have increased by 0.0% and is now trading at $1.25.

How were CynergisTek's earnings last quarter?

CynergisTek, Inc. (NYSEAMERICAN:CTEK) posted its earnings results on Thursday, November, 11th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.22. The company had revenue of $3.83 million for the quarter. CynergisTek had a negative trailing twelve-month return on equity of 42.78% and a negative net margin of 61.80%.

How do I buy shares of CynergisTek?

Shares of CTEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CynergisTek own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CynergisTek investors own include Corbus Pharmaceuticals (CRBP), BIOLASE (BIOL), Carnival (CCL), Peabody Energy (BTU), Dynavax Technologies (DVAX), GE Aerospace (GE) and Kinross Gold (KGC).

Company Calendar

• Last Earnings: 11/11/2021
• Today: 10/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Business Services
• Industry: Business Services
• Sub-Industry: N/A
• Current Symbol: NYSEAMERICAN:CTEK
• Previous Symbol: NYSEMKT:CTEK
• CIK: 1011432
• Web: www.cynergistek.com
• Phone: (512) 402-8550
• Fax: 949-614-0701
• Employees: 89
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.17)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.25 million
• Net Margins: -61.80%
• Pretax Margin: -30.59%
• Return on Equity: -42.78%
• Return on Assets: -36.36%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.69
• Quick Ratio: 1.69

Sales & Book Value

• Annual Sales: $16.30 million
• Price / Sales: 1.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.15 per share
• Price / Book: 1.09

Miscellaneous

• Outstanding Shares: 13,257,000
• Free Float: 11,852,000
• Market Cap: $16.57 million
• Optionable: Not Optionable
• Beta: 1.25